A low-mass-number metal-labeled probe, its preparation method, and its application in single-cell protein detection by mass cytometry.
By developing low-mass-number metal-labeled probes and utilizing functionalized polymer carriers to complex with metal ions and click chemical linkages to target and recognize molecules, the problem of the lack of low-mass-number probes in mass spectrometry flow cytometry detection has been solved, enabling reliable grouping and multi-parameter detection of complex cell subpopulations.
Patent Information
- Application Number
- CN202611332721.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-31
- Publication Date
- 2026-11-17
AI Technical Summary
The lack of low-mass-number metal tags in existing mass spectrometry flow cytometry detection technologies results in the absence of a systematic targeted probe system in the low-mass-number detection region, making it impossible to reliably group complex cell subpopulations.
We developed low-mass-number metal-labeled probes, which are complexed with metal ions using functionalized polymer carriers and DTPA or DOTA-type coordinating groups. The metal element mass number is less than 75 Da. These probes are then combined with targeted recognition molecules such as full-length antibodies or nanobodies, and covalently linked through click chemistry.
The mass spectrometry flow cytometry detection channel has been expanded, enabling stable loading and targeting activity of low mass number metal ions. It can reliably cluster at the single-cell level and is compatible with medium and high mass number probes, thus improving multi-parameter detection capabilities.
Smart Images

Figure CN123107075A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the fields of single-cell multi-parameter detection and metal-labeled probe technology, and in particular to a low-mass-number metal-labeled probe, its preparation method, and its application in single-cell protein detection by mass spectrometry flow cytometry. Background Technology
[0002] Cytometry (CyTOF) combines a single-cell flow cytometry system with inductively coupled plasma time-of-flight mass spectrometry (ICP-qTOF-MS), using metals as reporter molecules and antibodies as target reagents. It is one of the most advanced single-cell, high-sensitivity, high-throughput, multi-target detection platforms currently available. Compared to traditional flow cytometry, which relies on fluorophore emission spectra, Cytometry distinguishes reporter signals based on ion mass-to-charge ratios, significantly reducing the limitations of fluorescence spectral overlap, autofluorescence, and compensation errors on multi-parameter detection. It has become an important technique for analyzing immune cell heterogeneity, studying the tumor microenvironment, evaluating drug mechanisms of action, and performing in-depth immunophenotyping of clinical samples.
[0003] Currently, the metal-labeled probes in mass cytometry protein detection channels are mainly located in the mass number range of approximately 75–209 Da. Theoretically, a large number of isotopes can be selected, but commercially available, mature reagents are primarily concentrated in the medium-mass range (140–209 Da) of lanthanides. Therefore, the number of channels suitable for stable single-cell protein detection remains limited. Patent CN115975214A discloses a metal tag, its preparation method, and its application. This metal tag is mainly composed of lanthanides and UiO-66-(COOH)2. The abundant carboxyl groups in the UiO-66-(COOH)2 structure can effectively chelate metal ions, achieving a strong chelation capacity of approximately 10... 5 While there are several lanthanide metal ions, the existing technology has always been limited to lanthanide systems with medium to high mass numbers, failing to break through the mass number boundaries of existing channels. Furthermore, current technologies often conflate "elements detectable by mass spectrometry" with "elements that can be used as single-cell protein detection channels." In fact, a new detection channel expansion only constitutes a usable detection channel when it simultaneously meets multiple requirements, including stable probe loading, maintained targeting activity, positive / negative grouping, and compatibility with combined panels.
[0004] In recent years, domestically produced mass spectrometry flow cytometers have adopted industry-first "full-spectrum scanning" and "multi-mode ion gating" technologies. Their multi-mode quadrupole design enables the detection of stable metal isotopes with mass numbers ranging from 2 to 260 Da, significantly expanding the range compared to the 75-209 Da range of traditional CyTOF. This improved instrument capability provides a hardware foundation for developing low-mass-number metal tags (<80 Da), but the development of corresponding tagging reagents is still lacking, and a systematic targeted probe system for the low-mass-number detection region has not yet been established.
[0005] Therefore, there is an urgent need to develop a targeted probe system for low-mass-number detection regions that can reliably separate complex cell subpopulations under low-mass-number acquisition conditions and be integrated into a combined panel with lanthanide-labeled commercial reagents. Summary of the Invention
[0006] In view of the shortcomings of the prior art described above, the purpose of this invention is to provide a low mass number metal-labeled probe, its preparation method, and its application in mass spectrometry flow cytometry single-cell detection, in order to solve the problem of the lack of low mass number metal tags.
[0007] To achieve the above and other related objectives, the present invention provides a low mass number metal-labeled probe, comprising a functionalized polymeric carrier and a metal ion coordinated with the functionalized polymeric carrier, wherein the side chain or main chain of the functionalized polymeric carrier has a DTPA-type coordination group or a DOTA-type coordination group; the metal ion is coordinated with the DTPA-type coordination group or the DOTA-type coordination group, and the mass number of the metal element corresponding to the metal ion is less than 75 Da.
[0008] In this application, metallic elements with a mass number less than 75 Da are defined as low mass number metals, and metallic elements with a mass number of 75 Da or more are defined as medium mass number metals.
[0009] As a preferred embodiment of this application, the metal element is selected from... 55 Mn, 58 Ni、 60 Ni、 59 Co、 63 Cu and 65 Any one or more combinations of Cu.
[0010] As a preferred embodiment of this application, the functionalized polymer carrier is a metal chelate polymer comprising a main chain, a chelate ligand, and a reactive end group; wherein the main chain is selected from amino acids or acrylamide structures, the chelate ligand is selected from DOTA or DTPA, and the reactive end group is selected from maleimide or carboxyl groups.
[0011] As a further preferred embodiment of this application, the functionalized polymeric carrier comprises an amino acid backbone, a DTPA ligand, and a maleimide terminal group. Most preferably, the amino acid is lysine.
[0012] Most preferably, the structure of the functionalized polymer carrier is shown in Formula I:
[0013] Formula I
[0014] In the formula, n is 10-100.
[0015] As a preferred embodiment of this application, the method for preparing the functionalized polymer carrier (also referred to as the polymer) includes:
[0016] (1) Using 2-(2-azidoethoxy)ethylamine as an initiator, the ring-opening polymerization of cyclic lysine was initiated to obtain a polymer backbone structure;
[0017] (2) The DOTA or DTPA ligand is activated by HATU peptide condensation reagent and reacts with the amino groups in the polymer backbone to generate amide bonds, thereby covalently linking the DOTA or DTPA ligand to the polymer side groups.
[0018] (3) Maleimide is introduced as the end group of the polymer by using the click reaction between the azide group at the end of the main chain and the alkynyl maleimide.
[0019] As a further preferred embodiment of this application, the preparation process of the functionalized polymer carrier (hereinafter referred to as the polymer) shown in Formula I is as follows:
[0020] Step 1: Lys-Boc-NCA Synthesis
[0021] Using anhydrous dichloromethane (DCM) as solvent, under inert nitrogen protection, tert-butyloxycarbonyl-protected lysine (Lys-Boc) and triphosgene (BTC) were added at a molar ratio of 5:2. The mixture was heated to 50°C and refluxed for 3-4 hours until the system became clear. The solvent was removed by rotary evaporation, and the residue was recrystallized, centrifuged, and dried to obtain intermediate product 1 (Lys-NCA).
[0022] Step 2: Ring-opening polymerization of Lys-NCA yields polylysine (polymer Lys).
[0023] (1) Ring-opening polymerization of NCA: 774.8 mg (3.0 mmol) of intermediate product Lys-NCA was dissolved in 20 mL of anhydrous N,N-dimethylformamide (DMF). At 20-25 °C, 13.0 mg (0.1 mmol) of 2-(2-azidoethoxy)ethylamine was used as an initiator to carry out ring-opening polymerization by attacking the carbonyl group in intermediate product Lys-NCA with the primary amine group at the end of the initiator. The reaction time was 48 h to obtain polylysine with Boc protection on the side chain and azido groups at the chain ends. The monomer / initiator molar ratio was 30:1 to obtain polylysine with azido-terminated protected state and a target degree of polymerization of about 30.
[0024] (2) Deprotection of Boc group: The obtained protected polylysine was dispersed in 5 mL of anhydrous DCM, 5 mL of TFA was added, and the mixture was stirred at room temperature for 2 h. After removing the solvent by rotary evaporation, it was precipitated with 20 times the volume of cold methyl tert-butyl ether (MTBE) and washed. The mixture was then dried under vacuum to obtain a white solid polylysine backbone (polymer Lys) with azide groups retained at the chain ends.
[0025] Step 3: Condensation of polylysine (polymer Lys) with metal chelate ligand (APA-DTPA)
[0026] Condensation reaction: Based on 50.0 mg of N3-polymer-Lys (containing approximately 0.20 mmol ε-NH2 on a free base basis), 6.4 g of DTPA (16.3 mmol) was weighed, dissolved in 5M NaOH solution, and the pH was adjusted to 8.5. 452 mg of DMTMM (1.63 mmol) was weighed and dissolved in 2 mL of deionized water. The two solutions were premixed for 5 min, and then N3-polymer-Lys was added. The mixture was stirred at room temperature for 2 h. After the reaction, the solution was washed several times with deionized water in a 3 kD ultrafiltration tube, and the concentrated solution was collected and dried under vacuum. Amide bonds were formed between the amino groups of the polylysine (polymer Lys) side chain and the carboxyl groups of DTPA through an amidation reaction at room temperature.
[0027] Step 4: CuAAC Click Chemistry
[0028] Dissolve 50 mg of N3-polymer-DTPA in 30 mL of deoxyPBS, add 0.9 mg (6.0 μmol) of N-propyne maleimide, and stir for 5 min until fully dissolved. In a small deoxygenated centrifuge tube, add 0.3 mg CuBr (2.0 μmol) and 1.2 mg THPTA (2.4 μmol), then add 1 mL of deoxyPBS. Vortex and pre-complex in the dark for 2–3 min; the solution turns pale blue / colorless. Quickly inject the pre-complexed CuBr THPTA solution into the reaction flask; seal, protect under N2 protection, and stir at room temperature in the dark for 6–8 h. Dialyze / ultrafiltration to remove copper completely, and freeze-dry to obtain Ma-polymer-DTPA.
[0029] The synthetic route for the functionalized polymer support in this application is as follows:
[0030]
[0031] The metal chelating functional group DTPA in the above synthesis reaction can also be replaced with DOTA.
[0032] .
[0033] It should be noted that the above is for illustrative purposes only and does not constitute a limitation on the scope of this application. Those skilled in the art can also achieve the technical effects of this invention by using functional polymer carriers with the same structure from other similar manufacturers or synthesized by themselves.
[0034] As a preferred embodiment of this application, the targeted recognition molecule is selected from any one or a combination of two or more of the following: full-length antibody, antibody fragment retaining antigen-binding activity, nanobody, or nucleic acid aptamer.
[0035] The present invention also provides a low mass number metal-labeled antibody, comprising the aforementioned low mass number metal-labeled probe and a target recognition molecule covalently linked to a functionalized polymeric carrier in the low mass number metal-labeled probe.
[0036] As a preferred embodiment of this application, the targeted recognition molecule is selected from any one or a combination of two or more of the following: full-length antibody, antibody fragment retaining antigen-binding activity, nanobody, or nucleic acid aptamer.
[0037] As a further preferred embodiment of this application, the targeted recognition molecule is selected from any one or a combination of two or more of anti-CD3 antibodies, anti-CD4 antibodies, anti-CD8 antibodies, anti-CD14 antibodies, and anti-CD45 antibodies.
[0038] This invention also provides a method for preparing low mass number metal-labeled antibodies, comprising the following steps:
[0039] Step 1: Dissolve the metal salt in deionized water, mix thoroughly, centrifuge and collect the supernatant. Quantitatively determine the concentration of metal ions in the supernatant to prepare a metal working solution of a preset concentration; the mass number of the metal element contained in the metal salt is less than 75 Da.
[0040] Step 2: Mix the metal working solution with the functionalized polymer carrier thoroughly and incubate at 37°C for 20-40 min. After incubation, remove the unbound free metal ions in the system to obtain solution A containing the polymer chelating carrier.
[0041] Step 3: Mix the solution A with the target recognition molecule solution after thiol activation treatment, and react at 37 °C for 20-40 min to allow the polymer chelating carrier and the target recognition molecule to undergo a covalent coupling reaction, thereby obtaining a solution B containing a metal-labeled target recognition molecule complex.
[0042] Step 4: Remove unreacted free target recognition molecules and small molecule impurities from solution B, replace the purified metal-labeled target recognition molecule complex with the washing buffer, add protein stabilizer, and dispense to obtain the metal-labeled antibody.
[0043] Preferably, the metal salt is a low-mass-number transition metal chloride. More preferably, the metal salt is selected from one or more of manganese chloride, nickel chloride, cobalt chloride, and copper chloride, wherein the metal element in the metal salt exists in its naturally abundant stable isotopic form, including... 55 Mn, 58 Ni、 60 Ni、 59 Co、 63 Cu or 65 One or more of Cu are used in non-radioactive cold-labeled control experiments.
[0044] As a preferred embodiment of this application, the method for preparing low mass number metal-labeled probes according to the present invention further includes: step 5, evaluating the performance of the metal-labeled probe; wherein, the performance evaluation includes the metal element response sensitivity and linear range, target cell background signal, probe metal signal stability and storage stability, single staining positive / negative clustering effect, targeting specificity, accuracy of complex cell population clustering, and compatibility of the metal-labeled probe with calibration microspheres, tuning solution and medium- to high mass number metal-labeled probes.
[0045] As a preferred embodiment of this application, the metal-labeled probe and the detection reagent can be used to expand the detection channels of mass spectrometry flow cytometry, while meeting the following evaluation criteria:
[0046] (a) It can stably recognize target molecules at the single-cell level;
[0047] (b) Capable of forming repeatable cell clusters; and
[0048] (c) It does not interfere with the recognition signals of medium- to high-quality metal marker probes already configured in the same detection panel.
[0049] As a preferred embodiment of this application, the preset concentration of the metal salt in the metal working fluid is 10-200 mM. More preferably, the concentration of the metal salt is 50 mM.
[0050] As a preferred embodiment of this application, in step 1, the centrifugation speed is 10000g-15000g and the centrifugation time is 3-10 minutes. More preferably, in step 1, the centrifugation speed is 12000g and the centrifugation time is 5 minutes.
[0051] As a preferred embodiment of this application, in step 2, the ratio of the metal salt, the functionalized polymer carrier, and the targeted recognition molecule is 20 nmol: (0.1-0.3) mg: 667 pmol. More preferably, the ratio of the metal salt, the functionalized polymer carrier, and the targeted recognition molecule is 20 nmol: 0.2 mg, 667 pmol.
[0052] As a preferred embodiment of this application, step 3, the targeted recognition molecule is subjected to thiol activation treatment using the following method:
[0053] Prepare a homogeneous solution of the target recognition molecule at a preset concentration;
[0054] A disulfide bond selective reducing agent is added to a homogeneous solution of the targeted recognition molecule to selectively reduce the disulfide bonds of the molecule, thereby obtaining a solution system containing a reactive thiol group; and
[0055] The residual reducing agent in the solution system is removed and the buffer is replaced to obtain a targeted recognition molecule solution after thiol activation treatment.
[0056] As a preferred embodiment of this application, the disulfide bond selective reducing agent is tris(2-carboxyethyl)phosphine (TCEP). TCEP is characterized by being odorless, having mild reduction conditions, and high reduction efficiency, effectively maintaining the spatial conformation and biological activity of the targeted recognition molecule. Importantly, TCEP itself does not contain thiol groups, and its reduction products do not possess the ability to competitively react with subsequent coupling groups (such as maleimide). Therefore, when TCEP is used as a reducing agent, buffer replacement can be performed directly after the reaction without the need for an additional reducing agent removal step. This not only simplifies the process but also further reduces the risk of sample loss. Buffer replacement can be performed using ultrafiltration centrifugation. Specifically, the targeted recognition molecule solution, after being reduced and activated by TCEP, is transferred to an ultrafiltration centrifuge tube. The molecular weight cutoff of the ultrafiltration centrifuge tube should be less than the theoretical molecular weight of the targeted recognition molecule to ensure that the target molecule is effectively retained above the filter membrane, while the old buffer components of small molecules and residual TCEP (and its oxidation products) are removed with the filtrate. Subsequently, a predetermined volume of fresh buffer solution (wash buffer) is added to the ultrafiltration tube, and centrifugation is performed. This "liquid addition-centrifugation" washing step is repeated several times (preferably 3-5 times) until the old buffer solution is fully replaced. This method not only efficiently replaces the solution environment, providing a suitable reaction medium for subsequent coupling reactions, but also ensures that the ultrafiltration centrifugation operation is mild and time-efficient, effectively avoiding sample loss from repeated purification and further guaranteeing the recovery rate and bioactivity of the targeted recognition molecules. The entire ultrafiltration centrifugation process is performed at low temperatures (e.g., 0-8°C) to maintain protein activity.
[0057] As a preferred embodiment of this application, in step 2, the removal of unbound free metal ions from the system can be performed using ultrafiltration, dialysis, gel filtration, or other suitable methods. More preferably, in step 2, ultrafiltration centrifugation is used to remove unbound free metal ions from the system.
[0058] As a preferred embodiment of this application, in steps 2 and 3, the incubation temperature is 37°C and the incubation time is 30 min.
[0059] As a preferred embodiment of this application, step 4 is performed as follows: Transfer solution B to a centrifuge ultrafiltration tube, add 300 μL of washing buffer, mix well, centrifuge at 12000g for 10 minutes, discard the waste liquid, and then wash the filter cartridge solution three times with 400 μL of washing buffer, finally dispersing it in 100 μL of washing buffer. Calculate the antibody concentration using Nanodrop. Based on the protein concentration, add antibody stabilizer, mix well, and obtain a low mass number metal-labeled antibody reagent (final concentration 0.5 mg / mL).
[0060] As a preferred embodiment of this application, the medium-mass metal labeling probe is a lanthanide metal labeling probe.
[0061] Specifically, the present invention also provides a general method for preparing low-mass-number metal-labeled antibodies, comprising the following steps:
[0062] Preparation method of S1 metal chelate solution: Mix 5 μL of metal salt solution (50 mM) and 0.2 mg of polymer evenly. The reaction system is 100 μL of chelation buffer. Incubate at 37°C for 30-40 minutes. The final concentration of the metal element in the metal salt solution is 2.5 mM.
[0063] S2 Antibody Reduction: Add reduction buffer and pure antibody to an ultrafiltration tube with a molecular weight cutoff of 50 kDa, centrifuge at 12000g for 10 minutes, add TCEP reduction solution to the filter cartridge, mix well, and incubate at 37°C for 30 minutes to obtain an antibody solution with disulfate reduced to thiol groups; the TCEP reduction solution is prepared by adding 992 μL of reduction buffer to 8 μL of 0.5 M TCEP solution and mixing well.
[0064] S3, Purification of the metal chelate: Add an appropriate amount of chelation buffer to an ultrafiltration tube with a molecular weight cutoff of 3 kDa, then add the metal chelate solution obtained in step S1, mix well, centrifuge at 12000g for 25 min, and discard the waste liquid. Add an appropriate amount of chelation buffer to the filter cartridge, centrifuge at 12000g for 30 min, discard the waste liquid, and the purified metal chelate is retained in the filter cartridge;
[0065] S4. Antibody Purification: Add an appropriate amount of chelation buffer to the antibody solution reduced in step S2, centrifuge at 12000g for 10 min at room temperature, and wash twice. Discard the waste liquid after centrifugation to obtain the purified antibody;
[0066] S5 Preparation of metal-labeled antibody complex: Resuspend the metal chelate purified in step S3 with chelation buffer, add it to the antibody purified in step S4, mix well, and incubate at 37°C for 60-120 minutes to obtain the metal-labeled antibody complex.
[0067] S6 Washing the metal-labeled antibody complex: Wash the metal-labeled antibody complex obtained in step S5 with washing buffer, centrifuge at 12000g for 10 minutes, discard the waste liquid, and repeat three times;
[0068] The protein concentration of the S7 quantitative metal-labeled complex was 0.5 mg / mL.
[0069] Preferably, the low-mass metal element is manganese chloride, nickel chloride, cobalt chloride, or copper chloride, and the metal element in the metal salt exists in its natural abundance as a stable isotope, including... 55 Mn, 58 Ni、 60 Ni、 59 Co、 63 Cu or 65 One or more of Cu.
[0070] As a preferred embodiment of this application, the amounts of reduction buffer, pure antibody, and TCEP reduction solution are 300 μL, 100 μg, and 100 μL, respectively.
[0071] As a preferred embodiment of this application, in the above-mentioned method S3 for preparing mass cytometry antibodies, the volumes of the metal chelate solution and the chelation buffer are 100 μL and 200 μL, respectively.
[0072] As a preferred embodiment of this application, in step S4, the volumes of the first addition of chelation buffer are 300 μL and the second addition of chelation buffer are 400 μL.
[0073] As a preferred embodiment of this application, in step S5, the volume of chelation buffer added for resuspension is 60 μL.
[0074] As a preferred embodiment of this application, step S6 is as follows: Add 300 μL of washing buffer to the 50 kDa ultrafiltration tube containing the antibody complex obtained in S5, mix well, centrifuge at 12000g for 10 minutes, discard the waste liquid, and then wash the filter solution three times with 400 μL of washing buffer. Finally, add 80 μL of washing buffer to resuspend the solution in the filter tube.
[0075] As a preferred embodiment of this application, step S7 is as follows: Take 2 μL of liquid into the filter cartridge of S6. Using W-Buffer as a blank background, calculate the antibody recovery rate using Nanodrop. Based on the protein concentration, add antibody stabilizer, mix well, and obtain a low mass number metal-labeled antibody reagent with a final concentration of 0.5 mg / mL.
[0076] This invention also provides a polymeric chelating carrier for metal labeling, comprising a functionalized polymeric carrier and a metal ion coordinated and complexed with the functionalized polymeric carrier, wherein the side chain or main chain of the functionalized polymeric carrier has a DTPA-type coordination group or a DOTA-type coordination group; the metal ion is coordinated and complexed with the DTPA-type coordination group or the DOTA-type coordination group, and the mass number of the metal element corresponding to the metal ion is less than 75;
[0077] The polymeric chelating carrier is used to covalently link the target recognition molecule to form the low-mass metal-labeled antibody.
[0078] The present invention also provides the application of the low mass number metal-labeled probe, the detection reagent, or the low mass number metal-labeled antibody obtained by the preparation method in mass spectrometry flow cytometry single-cell protein detection.
[0079] As a preferred embodiment of this application, the application includes at least one of the following:
[0080] (1) Used for target detection in cell suspensions, fixed cells, tissue sections or mass spectrometry imaging;
[0081] (2) Used as quality coding for sample barcodes or cell barcodes.
[0082] This invention also provides a single-cell protein detection method based on mass spectrometry, comprising the following steps:
[0083] (a) The cell sample is stained using the low mass number metal-labeled probe, the low mass number metal-labeled antibody, or the low mass number metal-labeled antibody obtained by the preparation method described above;
[0084] (b) Acquiring the mass signal of the cell sample using a mass flow cytometer that supports the detection of low-mass-number metal ions; and
[0085] (c) The cell subpopulation is grouped according to the signal of the mass channel corresponding to the low mass number metal probe.
[0086] As a preferred embodiment of this application, the clustering includes distinguishing target positive cell populations from target negative cell populations based on the signal intensity of the mass channel corresponding to the low mass number metal probe.
[0087] As a preferred embodiment of this application, the single-cell protein detection method based on mass spectrometry further includes: co-incubating the cell sample with a commercially available lanthanide metal labeling reagent with a mass number higher than 75 at 37°C, and simultaneously collecting or jointly analyzing low-mass-number metal channels and lanthanide metal channels to group cell subpopulations.
[0088] The present invention also provides the application of the low mass number metal-labeled probe, the low mass number metal-labeled antibody, or the low mass number metal-labeled antibody obtained by the preparation method in non-diagnostic cell immunophenotypic analysis.
[0089] The present invention also provides the application of the low mass number metal-labeled probe, the low mass number metal-labeled antibody, or the low mass number metal-labeled antibody obtained by the preparation method in constructing a mass cytometry panel for multi-parameter cell detection across mass regions.
[0090] As a preferred embodiment of this application, the low-mass-number metal probe and the lanthanide metal-labeled commercial reagent are used together to construct a multi-parameter cell detection panel, and the signals of each probe do not interfere with each other. Complex cell subpopulations are identified based on the combined signals of the low-mass-number metal channel and the lanthanide metal channel.
[0091] This invention also provides a non-diagnostic method for cell immunophenotyping, comprising the step of labeling the cell sample to be tested using the aforementioned low-mass-number metal-labeled probe, the aforementioned low-mass-number metal-labeled antibody, or the low-mass-number metal-labeled antibody prepared by the aforementioned method. Using the proprietary probe of this application, in the low-mass ion-permeable acquisition state of mass cytometry, the signal of the mass channel corresponding to the probe is used to distinguish between target-positive and target-negative cell populations in the cell sample.
[0092] Compared with the prior art, the beneficial effects of the present invention are:
[0093] 1. Innovatively develop low-mass-number metals into mass spectrometry flow cytometry metal tags, using Mn, Ni, Co, and Cu as representative metals, to expand the existing metal tag system that is mainly concentrated in the medium-mass-number region;
[0094] 2. Construct a probe structure consisting of "low-mass-number metal ions—functionalized polymer carriers—targeted recognition molecules". Low-mass-number metal ions are complexed and loaded using multidentate ligands, and then linked to targeted recognition molecules such as antibodies through selective coupling groups, giving low-mass-number elements probe properties for single-cell protein detection.
[0095] 3. Establish a screening and verification chain from "detectable signal" to "usable channel", including solution response, cell background, probe stability, single staining clustering, specificity, repeatability and calibration system compatibility, so as to eliminate candidate quality coordinates that can only detect elements but cannot form reliable cell clusters;
[0096] 4. Achieve cross-quality synergy between low-quality channels and existing medium-to-high-quality channels. Low-quality probes can be integrated into the same panel as medium-to-high-quality probes such as lanthanides, identifying complex cell subpopulations without affecting the targeting and segmentation of each channel, demonstrating the practical value of the newly added channels for multi-parameter detection;
[0097] 5. Transform low-quality regions that were not originally used for protein detection into distributable and reusable single-cell protein detection channels. Each isotope and its matching probe validated by the above system corresponds to a new functional channel, which can improve the design freedom of complex panels and has application value in expanding detection channels and improving multi-parameter detection capabilities. Attached Figure Description
[0098] Figure 1 This graph shows the linear dynamic range test results for low-mass metal solutions using MSFLO; MSFLO tests were performed on low-mass solutions with a mass number of 10. 5 It exhibits good linearity within the signal range.
[0099] Figure 2 This demonstrates that low-mass-number metal-labeled probes are compatible with MSFLO calibration microspheres and tuning fluids.
[0100] Figure 3 The background signal is a low number of peripheral blood immune cells; (a) indicates that Co, Ni, and Mn are not expressed in the cells; (b) indicates that Cu and Zn are endogenous elements contained in the cells themselves.
[0101] Figure 4 This demonstrates the absorbance of low-mass metal-labeled probes, polymers, and antibodies before and after conjugation.
[0102] Figure 5 The cell clustering effect of single-staining tubes with low-mass metal-labeled probes; where (a) is a low-mass metal-labeled CD8 probe; (b) is... 55 Mn_CD3 probe; (c) is 58 Ni_CD45 probe; (d) is 63 Cu_CD45 probe; (e) is... 59 Co_CD14 probe; (f) is a Co_CD14 probe; 59 The cell clustering effect of the Co_CD4 probe was compared with that of the lanthanide metal probe. Low-mass-number monostained probes could all identify the corresponding target cell populations, demonstrating excellent targeting ability, and the clustering results were consistent with the lanthanide control.
[0103] Figure 6 The results showed consistency between low-mass-number metal-labeled probes and commercial lanthanide probes in cell clustering.
[0104] Figure 7 The cell clustering effect of the low-mass-number metal-labeled probe panel and the lanthanide probe control is shown; both have excellent consistency in identifying cell subpopulations in complex cell populations, and the low-mass-number probes do not interfere with each other.
[0105] Figure 8 The effect of a panel combining low-mass-number metal probes and lanthanide probes on cell population segmentation in quality control blood is shown. (a) is the detection panel; (b) is the cell gate logic; (c) is the percentage of cell subpopulations, which meets the requirements of the quality control blood subpopulation specifications; and (d) is the tSNE dimensionality reduction distribution of each subpopulation. This indicates that the low-mass-number probes do not interfere with each other and are compatible with lanthanide probes as a new detection channel for mass flow cytometry. Detailed Implementation
[0106] The following specific examples illustrate the implementation of the present invention. Those skilled in the art can easily understand other advantages and effects of the present invention from the content disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and various details in this specification can also be modified or changed based on different viewpoints and applications without departing from the spirit of the present invention.
[0107] It should be noted that the process equipment or apparatus not specifically mentioned in the following embodiments are all conventional equipment or apparatus in the art.
[0108] Furthermore, it should be understood that the existence of other method steps before or after the combined steps, or the insertion of other method steps between these explicitly mentioned steps, does not preclude the existence of other method steps before or after the combined steps, or the insertion of other method steps between these explicitly mentioned steps, unless otherwise stated. It should also be understood that the combined connection relationship between one or more devices / apparatus mentioned in this invention does not preclude the existence of other devices / apparatus before or after the combined devices / apparatus, or the insertion of other devices / apparatus between these explicitly mentioned devices / apparatus, unless otherwise stated. Moreover, unless otherwise stated, the numbering of each method step is merely a convenient tool for identifying each method step, and not for limiting the order of the method steps or limiting the scope of the invention. Changes or adjustments to their relative relationships, without substantially altering the technical content, should also be considered within the scope of the invention.
[0109] The buffer solution used in the general preparation method of low mass number metal-labeled antibodies in this application is from the metal labeling kit (catalog number: P04528) of Hangzhou Spectrum Medical Technology Co., Ltd.; the antibody stabilizer is from CANDOR@Bioscience, catalog number 222125. CuCl2, Bio-Leader CAS: 7447-39-4; CoCl2, Bio-Leader CAS: 7646-79-9; MnCl2, MREDA, CAS: 7773-01-5; NiCl2, Maclean C16957768; ZnCl2, Maclean C18393232; Anti-CD3 (manufacturer: Kuangbo; catalog number: A7581-bulk), Anti-CD45 (manufacturer: Kuangbo; catalog number: A6701-bulk), Anti-CD4 (manufacturer: Kuangbo; catalog number: A7601-bulk), Anti-CD8 (manufacturer: Kuangbo; catalog number: A6161-bulk), Anti-CD19 (manufacturer: Kuangbo; catalog number: A6361-bulk), CD66 (manufacturer: Biolegend; catalog number: 396904), Anti-CD14 (manufacturer: Biolegend; catalog number: 301802).
[0110] This application uses the functionalized polymer carrier (referred to as polymer) shown in Formula I as an example for illustration, and its preparation process is as follows:
[0111] Step 1: Synthesis of Lys-Boc-NCA
[0112] Under nitrogen protection, 2.46 g (10.0 mmol) of Lys-Boc was suspended in 80 mL of anhydrous THF. 1.2 g of triphosgene (BTC) (4.0 mmol) was dissolved in 20 mL of anhydrous THF and slowly added dropwise to the suspension over 30 min using a constant-pressure dropping funnel. After the addition was complete, the mixture was heated to 50 °C and refluxed for 3–4 h until the system became clear. Most of the solvent was removed by rotary evaporation, and the mixture was recrystallized three times with anhydrous ethyl acetate / n-hexane and dried under vacuum to obtain Lys-NCA.
[0113] Step 2: Ring-opening polymerization of Lys-NCA yields polylysine (polymer Lys).
[0114] (1) Ring-opening polymerization of NCA: Lys-NCA 774.8 mg (3.0 mmol) was dissolved in 20 mL of anhydrous DMF, and 13.0 mg (0.1 mmol) of 2-(2-azidoethoxy)ethylamine was added. The mixture was stirred at room temperature for 48 h with a monomer / initiator molar ratio of 30:1 to obtain azido-terminated protected polylysine with a target degree of polymerization of about 30.
[0115] (2) Deprotection of Boc group: The obtained protected polylysine was dispersed in 5 mL of anhydrous DCM, 5 mL of TFA was added under ice bath, and the mixture was stirred at room temperature for 2 h. After removing the solvent by rotary evaporation, the solid was precipitated with 20 times the volume of cold methyl tert-butyl ether (MTBE) and washed. The solid was then dried under vacuum to obtain a white solid, which yielded N3-polymer-Lys.
[0116] Step 3: Condensation of polylysine (polymer Lys) with metal chelate ligand (DTPA)
[0117] Weigh 6.4 g DTPA (16.3 mmol), dissolve in 5 M NaOH solution and adjust pH to 8.5. Weigh 452 mg DMTMM (1.63 mmol), dissolve in 2 mL deionized water. Premix the two solutions for 5 min, then add 50 mg N3-polymer-Lys and stir at room temperature for 2 h. After the reaction is complete, wash several times with deionized water in a 3 kD ultrafiltration tube, collect the concentrate, and dry under vacuum to obtain N3-polymer-DTPA.
[0118] Step 4: CuAAC Click Chemistry
[0119] 50 mg of N3-polymer-DTPA was dissolved in 30 mL of deoxyPBS. 0.9 mg of N-propyne maleimide was added and stirred for 5 min until fully dissolved. In a small deoxygenated centrifuge tube, 0.3 mg of CuBr and 1.2 mg of THPTA were dissolved in 1 mL of deoxyPBS. The mixture was vortexed and pre-complexed in the dark for 2–3 min until the solution turned pale blue / colorless. The pre-complexed CuBrTHPTA solution was rapidly injected into the reaction flask; the flask was sealed, protected with N2, and stirred at room temperature in the dark for 6–8 h. The reaction was terminated with EDTA-2Na, and copper was completely removed by dialysis / ultrafiltration at 3 kDa to obtain Ma-polymer-DTPA. The functionalized polymeric carrier prepared according to the above method was used in subsequent examples.
[0120] Example 1
[0121] This embodiment provides a general method for preparing low-mass-number metal-labeled antibodies (protocol A), including the following steps:
[0122] S1 Metal Chelate Solution Preparation Method: Mix 5 μL of metal salt solution (50 mM) and 0.2 mg of polymer evenly. The reaction system is 100 μL of chelation buffer (metal labeling kit from Hangzhou Pukang Medical Technology Co., Ltd., catalog number P04528). Incubate at 37°C for 30-40 minutes. The final concentration of the metal element in the metal salt solution is 2.5 mM. The low-mass metal element is in the form of manganese chloride, nickel chloride, cobalt chloride, or copper chloride. The metal element in the metal salt exists in its naturally abundant stable isotopic form, including... 55 Mn, 58 Ni、 60 Ni、 59 Co、 63 Cu or 65 One or more of Cu;
[0123] S2 Antibody Reduction: Add reduction buffer (metal labeling kit from Hangzhou Pukang Medical Technology Co., Ltd., catalog number P04528) and pure antibody to an ultrafiltration tube with a molecular weight cutoff of 50 kDa. Centrifuge at 12000g for 10 minutes. Add TCEP reduction solution to the filter cartridge, mix well, and incubate at 37℃ for 30 minutes to obtain an antibody solution reduced to thiol groups by disulfate. The TCEP reduction solution is prepared as follows: Add 992 μL of chelation buffer (metal labeling kit from Hangzhou Pukang Medical Technology Co., Ltd., catalog number P04528) to 8 μL of 0.5M TCEP solution (manufacturer: Thermo, catalog number: 77720) and mix well. The volumes of reduction buffer, pure antibody, and TCEP reduction solution are 300 μL, 100 μg, and 100 μL, respectively.
[0124] S3, Purification of the metal chelate: Add an appropriate amount of chelation buffer (metal labeling kit from Hangzhou Pukang Medical Technology Co., Ltd., catalog number P04528) to an ultrafiltration tube with a molecular weight cutoff of 3 kDa, then add the metal chelate solution obtained in step S1, mix well, centrifuge at 12000g for 25 min, and discard the waste liquid. Add an appropriate amount of chelation buffer to the filter cartridge, centrifuge at 12000g for 30 min, discard the waste liquid, and the purified metal chelate is retained in the filter cartridge; wherein, the volumes of the metal chelate solution and the chelation buffer are 100 μL and 200 μL, respectively;
[0125] S4. Antibody Purification: Add an appropriate amount of chelation buffer to the antibody solution reduced in step S2, centrifuge at 12000g for 10 min at room temperature, and wash twice. Discard the waste liquid after centrifugation to obtain the purified antibody; the first addition of chelation buffer is 300 μL, and the second addition is 400 μL.
[0126] S5 Preparation of metal-labeled antibody complex: Resuspend the metal chelate purified in step S3 with 60 μL of chelation buffer, add it to the antibody purified in step S4, mix well, and incubate at 37°C for 60-120 minutes to obtain the metal-labeled antibody complex.
[0127] S6 Washing the metal-labeled antibody complex: Wash the metal-labeled antibody complex obtained in step S5 with washing buffer, centrifuge at 12000g for 10 minutes, discard the waste liquid, and repeat three times;
[0128] The specific procedure is as follows: Add 300 μL of washing buffer to the 50 kDa ultrafiltration tube containing the antibody complex obtained in S5, mix well, centrifuge at 12000g for 10 minutes, discard the waste liquid, and then wash the filter solution three times with 400 μL of washing buffer. Finally, add 80 μL of washing buffer to resuspend the solution in the filter tube.
[0129] The protein concentration of the S7 quantitative metal-labeled complex was 0.5 mg / mL;
[0130] The specific steps are as follows: Take 2 μL of liquid into the S6 filter cartridge. Using W-Buffer as a blank background, calculate the antibody recovery rate using Nanodrop. Based on the protein concentration, add antibody stabilizer (manufacturer: CANDOR@Bioscience, catalog number 222125), mix well, and obtain a low mass number metal-labeled antibody reagent with a final concentration of 0.5 mg / mL.
[0131] The performance of the metal-labeled probe prepared in this embodiment was tested:
[0132] (1) Evaluate the distribution and clustering ability of low-mass-number metal-labeled antibody channel signals in different target cell populations:
[0133] The obtained metal-labeled probes were used for surface staining and mass cytometry detection of peripheral blood mononuclear cell samples or fixed cryopreserved cells. Detection was performed using single staining or combined staining with other metal-labeled antibodies to evaluate the performance of different target cell populations. 55 Mn channel signal distribution and its grouping capability.
[0134] Specifically, the process of incubating cells with the probe and then performing detection is as follows (protocol B):
[0135] Take 3 × 10 cells to be tested 6 One sample (source: routine human peripheral blood test sample) was centrifuged using PBS solution, the supernatant was discarded, and the cell pellet was retained.
[0136] Add cisplatin incubation solution to the cell pellet, vortex to mix, and incubate at room temperature for 3-5 minutes; prepare 1x cisplatin incubation solution by adding 1 μL of cisplatin incubation solution (manufacturer: Hangzhou Pukang Medical Technology Co., Ltd., catalog number P03536) to 1 mL of PBS or serum-free cell culture medium; each mL of 1x cisplatin incubation solution can incubate 10 cells. 7 For each cell, add the corresponding volume of 1x cisplatin incubation solution to the cell pellet, based on the cell count.
[0137] Add 2-5 times the volume of room temperature flow cytometry staining buffer, mix well to stop the labeling reaction, centrifuge at 400g for 5 minutes at room temperature; repeat washing once and discard the supernatant;
[0138] Add 5 μL of Fc receptor blocking reagent (manufacturer: biolegend, catalog number 422301) to the cell pellet and incubate at room temperature for 10 min;
[0139] Then, a low mass number metal-labeled probe mixture (containing multiple metal labels, see the examples below for specific panels) was added and incubated at room temperature for 30 min.
[0140] Add 2 mL of flow cytometry staining buffer (manufacturer: Hangzhou Pukang Medical Technology Co., Ltd., catalog number P03532) to each tube, centrifuge at 600-800 g for 5 minutes, discard the supernatant; repeat the washing once.
[0141] Add 125 nM of Ir (manufacturer: Hangzhou Pukang Medical Technology Co., Ltd., catalog number P03535) containing fixative and incubate at room temperature for 1 h or at 4 ℃ overnight;
[0142] Add 2 mL of flow cytometry staining buffer to each tube, centrifuge at 500-800 g for 5 minutes, and discard the supernatant;
[0143] Add 2 mL of cell loading buffer to resuspend the cells (manufacturer: Hangzhou Pukang Medical Technology Co., Ltd., catalog number P03047), centrifuge at 500-800 g for 5 minutes, and discard the supernatant;
[0144] Cells were resuspended in 1 mL of cell loading buffer, and 10% elemental calibration microspheres (manufacturer: Hangzhou Pukang Medical Technology Co., Ltd., catalog number P03533) were added. Detection was performed using a mass flow cytometer (manufacturer: Hangzhou Pukang Medical Technology Co., Ltd., model: MSFLO) that supports the detection of low-mass-number metal ions. The quadrupole of the instrument was in a working state that allowed the passage and collection of low-mass-number metal ions.
[0145] Example 2
[0146] This embodiment uses 55Mn was used to label anti-CD3 and anti-CD8 antibodies, respectively. The preparation process followed the general preparation method for low mass number metal-labeled antibodies (protocol A) in Example 1.
[0147] The performance of the metal-labeled probes prepared in this embodiment was tested. The obtained metal-labeled probes were used for surface staining and mass cytometry detection of peripheral blood mononuclear cell samples or fixed frozen cells. The experimental procedure followed protocol B, evaluating the targeting and segmentation ability of the 55Mn-CD8 and 55Mn-CD3 probes for CD8+ T cells and CD3+ T cells, respectively. Lanthanide metal-labeled antibodies 175Lu-CD8 and 165Ho-CD3 were used as controls. The results showed that both the low-mass-number probes and the lanthanide probes could specifically recognize the target cell subpopulations, and the subpopulation proportions were consistent.
[0148] Table 1: 55 Mn-CD8 single-anode panel
[0149]
[0150] This panel contains only one type of low-mass-number probe, called... 55 Mn-CD8 single anode tube.
[0151] Table 2: 55 Mn-CD3 single-anode panel
[0152]
[0153] This panel contains only one type of low-mass-number probe, called... 55 Mn-CD3 single anode tube.
[0154] Example 3
[0155] The difference between this embodiment and Embodiment 1 is that: copper chloride is used to label the anti-CD45 and anti-CD8 antibodies respectively, and the metal element is... 63 Cu, the preparation process is the same as in protocol A. All other process conditions are identical.
[0156] The performance of the metal-labeled probes prepared in this embodiment was tested. The obtained metal-labeled probes were used for surface staining and mass cytometry detection of peripheral blood mononuclear cell samples or fixed frozen cells. Detection was performed using single staining or combined staining with other metal-labeled antibodies. The experimental procedure followed protocol B. The targeting and segmentation ability of the 63Cu-CD8 and 63Cu-CD45 probes for CD8+ T cells, granulocytes, and non-granulocytes were evaluated, with lanthanide metal-labeled antibodies 175Lu-CD8 and 89Y-CD45 used as controls. The results showed that both the low mass number probes and the lanthanide probes could specifically recognize the target cell subpopulations, and the subpopulation proportions were consistent.
[0157] Table 3: 63 Cu-CD8 single-anode panel
[0158]
[0159] Table 4: 63 Cu-CD45 single-anode panel
[0160]
[0161] Example 4
[0162] The difference between this embodiment and Embodiment 1 is that: cobalt chloride is used to label the anti-CD14 and anti-CD8 antibodies, respectively, and the metal element is... 59 Co, the preparation process is the same as in protocol A. All other process conditions are identical.
[0163] The performance of the metal-labeled probes prepared in this embodiment was tested. The obtained metal-labeled probes were used for surface staining and mass cytometry detection of peripheral blood mononuclear cell samples or fixed frozen cells. Detection was performed using single staining or combined staining with other metal-labeled antibodies. The experimental procedure followed protocol B. The targeting and segmentation ability of the 59Co-CD8 and 59Co-CD14 probes on CD8+ T cells and monocytes were evaluated, respectively. Lanthanide metal-labeled antibodies 175Lu-CD8 and 139La-CD14 were used as controls. The results showed that both the low mass number probes and the lanthanide probes could specifically recognize the target cell subpopulations, and the subpopulation proportions were consistent.
[0164] Table 5: 59 Co-CD8 single-anode panel
[0165]
[0166] Table 6: 59 Co-CD14 single-anode panel
[0167]
[0168] Example 5
[0169] The difference between this embodiment and Embodiment 1 is that: anti-CD45 and anti-CD8 antibodies are labeled with nickel chloride, respectively, and the metal element is... 58 Ni was prepared according to protocol A. All other process conditions were the same.
[0170] The performance of the metal-labeled probes prepared in this embodiment was tested. The obtained metal-labeled probes were used for surface staining and mass cytometry detection of peripheral blood mononuclear cell samples or fixed frozen cells. Detection was performed using single staining or combined staining with other metal-labeled antibodies. The experimental procedure followed protocol B. The targeting and segmentation ability of the 58Ni-CD8 and 58Ni-CD45 probes for CD8+ T cells, granulocytes, and non-granulocytes were evaluated, with lanthanide metal-labeled antibodies 175Lu-CD8 and 89Y-CD45 used as controls. The results showed that both the low mass number probes and the lanthanide probes could specifically recognize the target cell subpopulations, and the subpopulation proportions were consistent.
[0171] Table 7: 58 Ni-CD8 single anode panel
[0172]
[0173] Table 8: 58 Ni-CD45 single-anode panel
[0174]
[0175] Example 6: Compatibility evaluation of low mass number metal-labeled probes with commercially available lanthanide metal-labeled reagents
[0176] The experimental procedure followed protocol B, introducing multiple low-mass-number probes and lanthanide probes simultaneously into the antibody staining panel, and setting up a lanthanide metal-labeled antibody control to evaluate the compatibility between different low-mass-number probes and their compatibility with commercial probes.
[0177] The results showed that different low-mass-number probes did not affect cell-specific recognition and were compatible with commercial probes.
[0178] Table 9: Human peripheral blood low mass number probe panel
[0179]
[0180] Example 7: Evaluation of the accuracy of low-mass-number probe clustering
[0181] The low-mass-number metal-labeled probes prepared in Examples 2 to 5 were mixed with commercially available lanthanide probes and incubated with multi-target proteins in quality control blood samples (manufacturer: Beckman Coulter; batch number: 7587315F) to read the proportions of different cell subpopulations in complex cell populations, including CD3+, CD4+, CD8+, CD19+, CD3+, CD4+, CD3+, CD8+, CD3-, and CD56+ cell subpopulations. The results showed that the proportions of each subpopulation were consistent with the quality control blood instructions, and the low-mass-number probes demonstrated good accuracy in cell segmentation.
[0182] Comparative Example 1
[0183] Cells were incubated with commercial lanthanide metal-labeled antibody probes (the metal labeling kit was from fluidigm, catalog number 201300) to evaluate the targeting ability of the commercial lanthanide probes to the corresponding positive cell populations.
[0184] The low mass number metal marker probes prepared in Examples 2-7 were detected using the same method as the product in Comparative Example 1.
[0185] from Figure 1 The results show that MSFLO testing of low mass number metal-labeled probes at 10 5 It exhibits good linearity within the signal range. Figure 5 The results show that low-mass-number single-staining probes can all identify the corresponding target cell populations, demonstrating excellent targeting ability, and the clustering results are consistent with the lanthanide control. Figure 7 The cell clustering results of the low-mass-number probe panel and the lanthanide probe control show that both exhibit excellent consistency in identifying cell subpopulations within complex cell populations, and the low-mass-number probes do not interfere with each other. From... Figure 8 The results show that low mass number probes do not interfere with each other and are compatible with lanthanide probes as a new detection channel for mass flow cytometry.
[0186] This application utilizes a low-mass metal solution (using four low-mass elements—Mn, Ni, Co, and Cu—as examples), a functionalized polymer carrier (peptide polymer chain), and a targeted recognition molecule (pure antibody) to prepare a low-mass metal-loaded mass cytometry antibody tag, successfully achieving subpopulation differentiation of complex cell populations. This invention develops a novel low-mass metal-labeled probe for mass cytometry, expanding the gap in low-mass metal probe reagents and applications for mass cytometry, and improving the multiplexing capability of mass cytometry. The addition of each detection channel is significant for mass cytometry to achieve higher-dimensional cell collaborative system analysis capabilities.
[0187] The above embodiments are for illustrating the implementation schemes disclosed in this invention and should not be construed as limiting the invention. Furthermore, various modifications listed herein, as well as variations in the methods and compositions of the invention, will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been specifically described in conjunction with various specific preferred embodiments, it should be understood that the invention should not be limited to these specific embodiments. In fact, various modifications as described above that are obvious to those skilled in the art to obtain the invention should be included within the scope of this invention.
Claims
1. A low mass metal labeled probe, characterized by, The invention includes a functionalized polymer carrier and a metal ion coordinated with the functionalized polymer carrier. The functionalized polymer carrier has DTPA-type or DOTA-type coordination groups on its side chain or main chain. The metal ion is coordinated with the DTPA-type or DOTA-type coordination group, and the mass number of the metal element corresponding to the metal ion is less than 75 Da.
2. The low mass number metal label probe of claim 1, wherein: The metal element is selected from any one or a combination of two or more of 55 Mn, 58 Ni, 60 Ni, 59 Co, 63 Cu and 65 Cu; the functionalized polymer carrier is a metal-chelating polymer comprising three parts, a backbone selected from an amino acid or an acrylamide structure, a chelating ligand selected from a DOTA or DTPA ligand, and a reactive end group selected from a maleimide or a carboxyl group.
3. A low mass metal labeled antibody, characterized in that, It includes the low mass number metal-tagged probe as described in claim 1 or 2 and the target recognition molecule covalently linked to the low mass number metal-tagged probe.
4. The low mass metal labeled antibody of claim 3, wherein, The targeted recognition molecule is selected from any one or a combination of two or more of the following: full-length antibody, antibody fragment retaining antigen-binding activity, nanobody, or nucleic acid aptamer.
5. The method for preparing a low mass number metal labeled antibody as claimed in claim 3 or 4, characterized in that, Includes the following steps: Step 1: Dissolve the metal salt in deionized water, mix thoroughly, centrifuge and collect the supernatant. Quantitatively determine the concentration of metal ions in the supernatant to prepare a metal working solution of a preset concentration; the mass number of the metal element contained in the metal salt is less than 75. Step 2: Mix the metal working solution with the functionalized polymer carrier thoroughly and incubate at 37°C for 30-40 minutes. After incubation, remove the unbound free metal ions in the system to obtain solution A containing the polymer chelating carrier. Step 3: Mix the solution A with the target recognition molecule solution after thiol activation treatment, and react at 37°C for 30-40 min to allow the polymer chelating carrier and the target recognition molecule to undergo a covalent coupling reaction, thereby obtaining a solution B containing a metal-labeled target recognition molecule complex. Step 4: Remove unreacted free target recognition molecules and small molecule impurities from solution B, replace the purified metal-labeled target recognition molecule complex with the storage buffer, add protein stabilizer, and aliquot to obtain the low mass number metal-labeled antibody.
6. The application of the low mass number metal-labeled probe according to claim 1 or 2, the low mass number metal-labeled antibody according to claim 3 or 4, or the low mass number metal-labeled antibody obtained by the preparation method according to claim 5 in mass spectrometry flow cytometry single-cell protein detection.
7. A method for single cell protein detection based on mass flow, characterized by, Includes the following steps: (a) The cell sample is stained using the low mass number metal-labeled probe of any one of claims 1-3, the low mass number metal-labeled antibody of claim 4, or the low mass number metal-labeled antibody obtained by the preparation method of claim 5; (b) Acquire the mass signal of the cell sample using a mass flow cytometer that supports the detection of low mass number metal ions; as well as (c) The cell subpopulation is grouped according to the signal of the mass channel corresponding to the low mass number metal probe.
8. The mass spectrometry flow-based single-cell protein detection method of claim 7, wherein, The clustering includes distinguishing target-positive cell populations from target-negative cell populations based on the signal intensity of the mass channel corresponding to the low-mass-number metal probe.
9. The mass cytometry-based single-cell protein detection method according to claim 7 or 8, wherein, It also includes co-incubating the cell samples with commercially available lanthanide metal labeling reagents with a mass number higher than 75, and simultaneously collecting or jointly analyzing low-mass-number metal channels and lanthanide metal channels to group cell subpopulations.
10. Use of the low mass number metal labeled probe of claim 1 or 2, the low mass number metal labeled antibody of claim 3 or 4, or the low mass number metal labeled antibody obtained by the method of claim 5 in the construction of a mass spectrometric flow cross mass region multiparameter cellular detection panel.
Citation Information
Patent Citations
Metal tag and preparation method and application thereof
CN115975214A
